TTrialPathMatch Me to Trials
← Back to trials
RecruitingType 1 Diabetes

Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The proposed study is designed to test the hypothesis that treatment of resveratrol for 12 weeks will improve both endothelin-B receptor (aim 1) and skeletal muscle mitochondrial function (aim 2) in people with type 1 diabetes.

Sponsor: Augusta University

You may qualify if…

  • ✓ Men and premenopausal women
  • ✓ All races
  • ✓ Clinical diagnosis of insulin-dependent type 1 diabetes (patients only)

You may not qualify if…

  • ✕ Clinical diagnosis of hepatic, cardiovascular, or renal disease
  • ✕ Uncontrolled diabetes (HbA1C \>12%)
  • ✕ Diabetic complications (i.e. neuropathy)
  • ✕ Uncontrolled hypertension (\>140/90 mm Hg on therapy)
  • ✕ Pregnancy
  • ✕ Use of vasoactive medications

Where it's recruiting

Georgia

Augusta

Source: ClinicalTrials.gov · NCT04449198 · last updated 2025-01-28